 |
 |
 |
 |
 |
|
|
| Article 1 to 7 out of 7 concerning GeneNews Ltd. (formerly ChondroGene Limited)
|
-
Genenews adds two members to its Board of Directors
(05/07/2008)
GeneNews Limited announced its shareholders recently elected two additional members to its Board of Directors, Mr. Harry A. Glorikian and Ms. Fran Tuttle. They join Mr. Rory Riggs, Mr. James Howard-Tripp, Mr. Garth MacRae, Dr. Heiner Dreismann, Dr. ...
-
GeneNews secures $2 million for development of prostate biomarkers
(08/15/2007)
GeneNews Limited announced it has signed an agreement with an Asian Biomedical consortium to develop blood-based biomarkers for the detection and management of prostate diseases. Under the agreement, the consortium will provide US$2 million to ...
-
Chondrogene reports on blood-based prostate cancer diagnostic test development
(03/24/2006)
ChondroGene Limited reported on the progress of its ProstateSentry(TM) blood-based prostate cancer detection test. Results from the ProstateSentry test done with a simple blood sample in combination with measured PSA levels, differentiate aggressive ...
-
ChondroGene Enters Into Agreement with Kaiser Permanente
(11/01/2005)
Development of Database for Clinical Information
ChondroGene Limited announced that it has entered into an agreement with the Division of Research of the Permanente Medical Group of Northern California, to jointly develop a research database infrastructure that will be used for genomic research. ...
-
ChondroGene Enters into a Broad Alliance with UCSF
(08/17/2005)
Applying the Sentinel Principle for New Diagnostics and Therapeutics
ChondroGene Limited announced that it has entered into an alliance with the University of California, San Francisco (UCSF). The alliance provides a framework for ChondroGene to enter into collaborations with UCSF scientific researchers and ...
-
ChondroGene Published Genetic Marker Paper
(08/13/2004)
Toronto. ChondroGene Limited announced that the paper entitled "Genetic Markers: Progress and Potential for Cardiovascular Disease" has been published in a recent Supplement to Circulation. The Supplement entitled "Markers of Malign Across the ...
-
ChondroGene published paper ´Human genome project and cardiovascular disease genes´
(07/28/2004)
In landmark textbook ´Molecular Basis of Cardiovascular Disease´
Toronto. ChondroGene Limited announced publication of a timely review paper entitled, Human genome project and cardiovascular disease genes authored by Dr. C.C. Liew, Chief Scientific Officer and co-founder of ChondroGene Limited and Dr. Victor J. ...
 |
|
|
|
|